January 26, 2017
AstraZeneca’s Symbicort for asthma available for 6-12 y.o. children in USA, FDA issues exclusivity rights
AstraZeneca’s Symbicort Inhalation Aerosol is going to be available for 6-12 years old children with asthma in the US